wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41544681-35479E03-47F0-4D80-8DC2-0B3C4C8CFE73
Q41544681-35479E03-47F0-4D80-8DC2-0B3C4C8CFE73
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41544681-35479E03-47F0-4D80-8DC2-0B3C4C8CFE73
Comment on "combination treatment including targeted therapy for advanced hepatocellular carcinoma".
P2860
Q41544681-35479E03-47F0-4D80-8DC2-0B3C4C8CFE73
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41544681-35479E03-47F0-4D80-8DC2-0B3C4C8CFE73
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11d670ffa1ac299d9dd3ac8ea61f28ead7a34c5d
P2860
ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α.